CSPIA
TNDM icon

Cary Street Partners Investment Advisory’s Tandem Diabetes Care TNDM Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5
Closed -$104 – 1701
2023
Q3 		$104 Buy
+5
New +$137 ﹤0.01% 1847

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cary Street Partners Investment Advisory's TNDM Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Tandem Diabetes Care (TNDM) in Q4 2023, closing a stake of 5 shares — an estimated $104 sold.

Cary Street Partners Investment Advisory first reported a position in TNDM in Q3 2023 and held it in 1 quarter. The position peaked at $104 in Q3 2023. 268 funds tracked by Wall St. Rank hold TNDM as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining Tandem Diabetes Care position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 5 Tandem Diabetes Care shares in Q4 2023, an estimated $104.
  • Cary Street Partners Investment Advisory first reported a position in Tandem Diabetes Care in Q3 2023 and held it in 1 quarter.
  • Cary Street Partners Investment Advisory's Tandem Diabetes Care position peaked at $104 in Q3 2023.
  • 268 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.